Screening
0
Comments on “Can Colonoscopy Still Be Promoted as the Best Choice for Colorectal Cancer Screening?”
0

In the recently published article “Can Colonoscopy Still Be Promoted as the Best Choice for Colorectal Cancer Screening?,” Ladabaum et al1 propose that ...

0
Interventions for Increasing Colorectal Cancer Screening Uptake: A Systematic Review and Network Meta-Analysis
0

Programs that guide patients through screening or mail stool test kits to their homes most effectively increase colorectal cancer screening, especially in ...

0
Fecal Hemoglobin-Guided Precision Postpolypectomy Surveillance Within the Current Framework: A Four-Million-Participant Fecal Immunochemical Test–Based Screening Study
0

Fecal hemoglobin concentration-guided surveillance strategy balances the effectiveness and efficiency of colorectal cancer screening, enabling ...

0
Rethinking Screening Paradigms: 13-Year NordICC Data Comparing Colonoscopy to no Screening Show Reduction in Colorectal Cancer Incidence but not Mortality
0

Rethinking Screening Paradigms: 13-Year NordICC Data Comparing Colonoscopy to no Screening Show Reduction in Colorectal Cancer Incidence but not Mortality ...

0
Validated Early Detection Metrics Reduce the Population Requiring Liver Fibrosis Screening
0

Current liver screening targets 60%–76% of adults, while refined criteria limit screening safely to 10%–22%. This makes liver fibrosis screening more ...

0
Long-Term Follow-Up From the Barrett’s Esophagus Screening Trial 3 Demonstrates High Negative Predictive Value of Capsule Sponge–Trefoil Factor 3 Test for Esophageal Adenocarcinoma
0

Diagnosis of symptomatic esophageal adenocarcinoma (EAC) leads to poor survival and morbid treatments.1 Identifying individuals with the precursor condition ...

0
CME Exam 1: Fecal Hemoglobin-Guided Precision Postpolypectomy Surveillance Within the Current Framework: A Four-Million-Participant Fecal Immunochemical Test–Based Screening Study
0

CME Exam 1: Fecal Hemoglobin-Guided Precision Postpolypectomy Surveillance Within the Current Framework: A Four-Million-Participant Fecal Immunochemical ...

0
Too High, Just Right, or Not Enough? Rethinking α-Fetoprotein Thresholds for Hepatocellular Carcinoma Screening
0

α-Fetoprotein (AFP), a serum glycoprotein, is the first and most well-validated biomarker for hepatocellular carcinoma (HCC) detection.1 Although AFP has ...

0
Delivering high-quality aluminum dross ball mill and screening machine to our valued customer in South Africa
0

Delivering high-quality aluminum dross ball mill and screening machine to our valued customer in South Africa ...

0
Changes in Liver Disease Etiology Support a Lower Alpha-Fetoprotein Threshold for Hepatocellular Carcinoma Screening
0

In this study, we estimated the serum alpha-fetoprotein test’s performance for liver cancer screening in patients with cirrhosis. We found that lowering the ...

Daily Deals
Logo
Compare items
  • Total (0)
Compare
0
Shopping cart